Oxygen Ingress: The Silent Threat to Parenteral Stability and Product Integrity
The stability of a drug product in parenteral manufacturing is inextricably linked to the primary packaging’s ability to maintain a...
The stability of a drug product in parenteral manufacturing is inextricably linked to the primary packaging’s ability to maintain a...
Sterile injectable pharmaceutical manufacturing operates within tightly controlled environments where contamination control is critical. Cleanrooms are designed to minimise risk,...
Fibre contamination remains one of the most persistent and costly quality challenges in sterile injectable manufacturing. In environments where sterile...
As advancements in drug-development technology continue, solid oral dosage forms (SODFs) are now produced in an ever-expanding range of shapes,...
The Parenteral Drug Association (PDA) India Chapter hosted its 2025 Annual Conference in Hyderabad in late July, drawing over 600...
Controlled-release pharmaceutical tablets have long been a cornerstone of modern medicine. From critical heart medications to diabetes management, precise drug...
Container Closure Integrity Testing (CCIT) is a critical element especially for injectable drugs wherein even minor breaches in container closure...
In facilities producing biologics and mammalian cell culture APIs, pH buffers such as phosphate, acetate, and citrate are ever-present, used...
Softgel manufacturers are familiar with the difficulties associated with cleaning gelatin build-up, plasticizers, oils and pigments. Removing these tough residues...